Keywords
Arthritis ×
Eligibility Determination ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

19 Search results.

Efficacy of ofatumumab in adult patients with active rheumatoid arthritis with inadequate response to methotrexate NCT00611455 - Screen - Vital Signs; Medical Conditions; Eligibility Question; Neurological Examination; ECG

- 3/17/20 - 1 form, 5 itemgroups, 12 items, 1 language
Itemgroups: Vital Signs, Medical Conditions, Eligibility Question, Neurologic Examination, ECG
Study ID: 110635 Clinical Study ID: 110635 Study Title: A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy in adult patients with active rheumatoid arthritis who had an inadequate response to methotrexate therapy (FINAL ANALYSIS: follow-up period and cumulative safety data across the whole study) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00611455 Sponsor: GlaxoSmithKline Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ofatumumab, Placebo Study Indication: Arthritis, Rheumatoid

Eligibility Psoriatic Arthritis NCT02470481

- 3/4/20 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics; ODM derived from: https://clinicaltrials.gov/show/NCT02470481

Eligibility Early Inflammatory Arthritis NCT01347372

- 12/8/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Peer to Peer Mentoring For Individuals With Early Inflammatory Arthritis: An Effectiveness Study (Pilot RCT)- Peer Mentor Training; ODM derived from: https://clinicaltrials.gov/show/NCT01347372

Eligibility Inflammatory Arthritis NCT02144272

- 4/18/19 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02144272

Eligibility Degenerative Arthritis NCT02038140

- 3/13/19 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Zimmer Trabecular Metal Total Ankle; ODM derived from: https://clinicaltrials.gov/show/NCT02038140

Eligibility Lupus Arthritis, Systemic Lupus Erythematosus NCT01683695

- 1/17/19 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety Study of AMG 557 in Subjects With Lupus Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01683695

Eligibility Enthesitis Related Arthritis (ERA) NCT01166282

- 1/16/19 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01166282

Eligibility Juvenile Idiopathic Arthritis NCT01287715

- 1/16/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01287715

Eligibility Juvenile Idiopathic Arthritis NCT02024334

- 1/16/19 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02024334

Eligibility Basilar Joint Arthritis NCT01045694

- 12/6/18 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Botulism Toxin Injection as a Treatment for Arthritis of the Basal Thumb Joint; ODM derived from: https://clinicaltrials.gov/show/NCT01045694

Eligibility Inflammatory Arthritis NCT00808496

- 5/7/18 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Effect of Biannual Monitoring With Magnetic Resonance Imaging (MRI), X-ray, or Usual Care on Treatment for Inflammatory Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00808496

Eligibility Hip Arthritis NCT00894218

- 4/23/18 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
New Tool of Subjective and Objective Functional Evaluation and the Quality of Life After Arthroplastic Surgery of the Hip and the Knee Assisted or Not by Computer and Mini-invasive Arthroplasty; ODM derived from: https://clinicaltrials.gov/show/NCT00894218